R. Erik Holmlin - Feb 15, 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: President and CEO, Director
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol: BNGO
Transactions as of: Feb 15, 2025
Transactions value $: -$292
Form type: 4
Date filed: 2/19/2025, 06:56 PM
Previous filing: Jun 5, 2024
Next filing: Mar 18, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Tax liability	-$292	-51	-2.51%	$5.73	1.98K	Feb 15, 2025	Direct	F1, F2, F3
holding	BNGO	Common Stock						8	Feb 15, 2025	Robert Erik Holmlin Traditional IRA	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
F2	On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 120,428 less shares of common stock (119,934 less shares held directly and 494 less shares held indirectly).
F3	Includes 2 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024 (As adjusted for the January 2025 Reverse Stock Split).